No Data
No Data
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
GeneDx Holdings Corp. (NASDAQ:WGS) has made the biggest gains on the Russell 2000 Index in 2024 as the biotechnology company moves toward more comprehensive genetic testing.The Maryland-based company'
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
June closed on a high note for the stock market, with the S&P 500, tracked by the SPDR S&P 500 ETF Trust (NYSE:SPY), gaining 3.2%, despite significant disparities in sector and industry performances.T
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
TD Cowen Maintains Avidity Biosciences(RNA.US) With Buy Rating, Announces Target Price $56
TD Cowen analyst Ritu Baral maintains $Avidity Biosciences(RNA.US)$ with a buy rating, and sets the target price at $56.According to TipRanks data, the analyst has a success rate of 45.0% and a total
Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
Contineum Therapeutics, Inc. (NASDAQ:CTNM), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific
Have Insiders Sold Avidity Biosciences Shares Recently?
We'd be surprised if Avidity Biosciences, Inc. (NASDAQ:RNA) shareholders haven't noticed that the Chief Human Resources Officer, Teresa McCarthy, recently sold US$386k worth of stock at US$39.13 per s
No Data
NVDAvsTSLA : Just one small interest rate cut made everyone happy
Sigma-Jobs : OK, very good